Sign In
Buy CYDY
$0.276
-0.0143 (-4.93%)
At Close: Jun 03, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY
05:20am, Tuesday, 06'th Apr 2021
NEW YORK, April 6, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CytoDyn Inc. ("CytoDyn" or the "Company") (OTCMKTS: CYDY). Such investors are advised to c
CytoDyn Reschedules Webcast from April 6 to April 7
04:29pm, Monday, 05'th Apr 2021
VANCOUVER, Washington, April 05, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 14
CytoDyn executes $28.5M convertible note financing with institutional investor to speed up leronlimab manufacturing
09:34am, Monday, 05'th Apr 2021
CytoDyn Inc (OTCQB:CYDY), a biotechnology company developing its flagship drug Vyrologix (leronlimab-PRO 140) for multiple indications, announced Monday that it has completed an additional potentially
New York, New York--(Newsfile Corp. - April 5, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
VANCOUVER, Washington, April 05, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 an
VANCOUVER, Washington, April 05, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 14
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc. - CYDY
04:31pm, Saturday, 03'rd Apr 2021
Radnor, Pennsylvania--(Newsfile Corp. - April 3, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against CytoDyn
LOS ANGELES--(BUSINESS WIRE)---- $CYDY #CYDY--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc.
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CytoDyn, Inc. (CYDY) Investors
08:00am, Friday, 02'nd Apr 2021
LOS ANGELES, April 2, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired
New York, New York--(Newsfile Corp. - April 2, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytoDyn Inc. (OTC: CYDY) alleging that the
New Orleans, Louisiana--(Newsfile Corp. - April 1, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have u
CytoDyn (CYDY) Files New Protocol With FDA for COVID-19 Study
01:38pm, Thursday, 01'st Apr 2021
CytoDyn (CYDY) submits a new protocol with the regulatory body in the United States to study a higher dose of leronlimab for severely-infected COVID-19 patients.
New York, New York--(Newsfile Corp. - April 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
Radnor, Pennsylvania--(Newsfile Corp. - April 1, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against CytoDy
LOS ANGELES--(BUSINESS WIRE)---- $CYDY #CYDY--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytoDyn Inc.
